SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Jan-22 8:34 PM View: | Mirati Therapeutics, Inc. (MRTX) | 18-Jan-22 | Sale | 533 | $120.48 | $64,217.20 | (3%) 15.9K to 15.37K | |
18-Jan-22 8:34 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Jan-22 | Grant | 5,377 | -- | -- | 51% 10.53K to 15.9K | |
07-Jan-22 8:26 PM View: | Mirati Therapeutics, Inc. (MRTX) | 07-Jan-22 | Market Sale | 345 | $135.94 | $46,900.00 | (3%) 10.87K to 10.53K | (< 1%) |
06-Jan-22 4:50 PM View: | Mirati Therapeutics, Inc. (MRTX) | 04-Jan-22 | Market Sale | 758 | $147.74 | $111,987.00 | (7%) 11.63K to 10.87K | 7% |
20-Jan-21 6:18 PM View: | Mirati Therapeutics, Inc. (MRTX) | 15-Jan-21 | Grant | 4,157 | -- | -- | 56% 7.47K to 11.63K | |
08-Jan-21 7:57 PM View: | Mirati Therapeutics, Inc. (MRTX) | 07-Jan-21 | Market Sale | 241 | $216.33 | $52,134.90 | (3%) 7.71K to 7.47K | (1%) |
08-Jan-21 7:57 PM View: | Mirati Therapeutics, Inc. (MRTX) | 06-Jan-21 | Market Sale | 538 | $210.39 | $113,190.00 | (7%) 8.25K to 7.71K | (4%) |
15-Jan-20 7:38 PM View: | Mirati Therapeutics, Inc. (MRTX) | 06-Jan-20 | Grant | 2,750 | -- | -- | 50% 5.5K to 8.25K |